Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Undergraduate School

Williams College

1982, Williamstown, MA

Medical School

George Washington University

1986, Washington, DC

Internship

George Washington University Medical Center

1988, Washington, DC

Residency

George Washington University Medical Center

1988, Washington, DC

Residency

North Carolina Baptist Hospital; Bowman Gray School of Medicine

Winston-Salem, NC

Certifications

  • American Board of Pathology (Anatomic Clinical Pathology)
  • American Board of Pathology (Anatomic Cytopathology)

Publications

  1. Common queries in managing rhabdomyosarcoma in low- and middle-income countries: An Indo-North American collaboration. Pediatr Blood Cancer. 2023 11; 70(11):e30616. View Abstract

  2. Splenic Lymphatic Malformation With Papillary Endothelial Proliferation: A Rare Histologic Variant or a Unique Entity? Am J Surg Pathol. 2023 08 01; 47(8):915-925. View Abstract

  3. TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report. Pediatr Blood Cancer. 2023 May 17; e30413. View Abstract

  4. Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nat Commun. 2023 05 06; 14(1):2636. View Abstract

  5. Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2023 04 10; 41(11):2098-2107. View Abstract

  6. Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group. Eur J Cancer. 2022 Sep; 172:264-275. View Abstract

  7. An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials. Pediatr Blood Cancer. 2022 04; 69(4):e29511. View Abstract

  8. Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma. Arch Pathol Lab Med. 2021 12 01; 145(12):1564-1568. View Abstract

  9. Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer Med. 2021 02; 10(3):857-866. View Abstract

  10. The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group. Eur J Cancer. 2021 01; 143:127-133. View Abstract

  11. Beyond the tubule: pathological variants of LRP2, encoding the megalin receptor, result in glomerular loss and early progressive chronic kidney disease. Am J Physiol Renal Physiol. 2020 12 01; 319(6):F988-F999. View Abstract

  12. The application of current classification systems in pediatric cytopathology: Perspectives from the pediatric cytopathology symposium at the 20th International Congress of Cytology 2019. Cancer Cytopathol. 2019 10; 127(10):625-631. View Abstract

  13. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019 03; 109:36-50. View Abstract

  14. The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2019 01 15; 125(2):290-297. View Abstract

  15. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2018 09 20; 36(27):2770-2777. View Abstract

  16. Performance Characteristics of Cerebrospinal Fluid Cytology: An Analysis of Responses From the College of American Pathologists Nongynecologic Cytopathology Education Program. Arch Pathol Lab Med. 2018 07; 142(7):833-837. View Abstract

  17. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Endocr Pathol. 2018 Mar; 29(1):68-74. View Abstract

  18. Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2018 05 01; 124(9):1973-1981. View Abstract

  19. Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach. Pediatr Hematol Oncol. 2017 May; 34(4):231-237. View Abstract

  20. GM2 Activator Deficiency Caused by a Homozygous Exon 2 Deletion in GM2A. JIMD Rep. 2018; 38:61-65. View Abstract

  21. Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Dec; 64(12). View Abstract

  22. Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging. Pediatr Radiol. 2017 Apr; 47(4):484-487. View Abstract

  23. Hippocampal Formation Maldevelopment and Sudden Unexpected Death across the Pediatric Age Spectrum. J Neuropathol Exp Neurol. 2016 Oct; 75(10):981-997. View Abstract

  24. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis. Thyroid. 2016 10; 26(10):1466-1471. View Abstract

  25. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016 Oct; 17(10):1396-1408. View Abstract

  26. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer. 2016 10; 63(10):1737-43. View Abstract

  27. Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group. J Surg Oncol. 2016 Mar; 113(4):351-4. View Abstract

  28. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Apr; 63(4):634-9. View Abstract

  29. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jan; 63(1):54-61. View Abstract

  30. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. J Clin Oncol. 2015 Jul 10; 33(20):2279-87. View Abstract

  31. Adrenal Insufficiency in Mitochondrial Disease: A Rare Case of GFER-Related Mitochondrial Encephalomyopathy and Review of the Literature. J Child Neurol. 2016 Feb; 31(2):190-4. View Abstract

  32. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Arch Pathol Lab Med. 2015 Oct; 139(10):1281-7. View Abstract

  33. Myogenic tumors in nevoid Basal cell carcinoma syndrome. J Pediatr Hematol Oncol. 2015 Mar; 37(2):147-9. View Abstract

  34. Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Am J Surg Pathol. 2015 Feb; 39(2):245-50. View Abstract

  35. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment. Ann Oncol. 2015 Feb; 26(2):407-14. View Abstract

  36. Postmortem imaging in congenital heart disease: preliminary experience. Acta Radiol. 2015 Oct; 56(10):1264-72. View Abstract

  37. Neuropathology of 22q11 deletion syndrome in an infant. Pediatr Dev Pathol. 2014 Sep-Oct; 17(5):386-92. View Abstract

  38. Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney. Pediatr Nephrol. 2014 Nov; 29(11):2139-46. View Abstract

  39. Myogenin, AP2ß, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. Am J Surg Pathol. 2014 May; 38(5):654-9. View Abstract

  40. Cytopathology of pediatric malignancies: where are we today with fine-needle aspiration biopsies in pediatric oncology? Cancer Cytopathol. 2014 May; 122(5):322-36. View Abstract

  41. Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature. J Neuroophthalmol. 2014 Mar; 34(1):39-43. View Abstract

  42. Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers. Cancer. 2014 Apr 01; 120(7):1068-75. View Abstract

  43. Mutations in Hedgehog pathway genes in fetal rhabdomyomas. J Pathol. 2013 Sep; 231(1):44-52. View Abstract

  44. Incidental capture of rarely diagnosed pediatric tumor: an infant boy with clear cell sarcoma of the kidney. Urology. 2013 Dec; 82(6):1416-8. View Abstract

  45. Postmortem imaging of antemortem myocardial ischaemia. Eur Radiol. 2014 Jan; 24(1):34-41. View Abstract

  46. Hypercalcemia and miliary sarcoidosis in a 15-year-old boy. Arthritis Rheum. 2013 Aug; 65(8):2112. View Abstract

  47. Knee pain in a 9-year-old girl. Clin Orthop Relat Res. 2013 Oct; 471(10):3367-71. View Abstract

  48. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol. 2013 Jul; 140(1):82-90. View Abstract

  49. MAP plus maintenance pegylated interferon a-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization. J Clin Oncol. 2013 Jun 20; 31(18_suppl):LBA10504. View Abstract

  50. Radiology quiz case 1. Diagnosis: congenital cervical teratoma. JAMA Otolaryngol Head Neck Surg. 2013 Jun; 139(6):643-5. View Abstract

  51. Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2013 Mar; 60(3):371-6. View Abstract

  52. Left ventricular aneurysm, aortic stenosis, and arcade mitral valve: coexistence of three rare congenital heart defects. Pediatr Cardiol. 2012 Oct; 33(7):1206-9. View Abstract

  53. Cardiac paraganglioma in an adolescent. Circulation. 2012 Feb 07; 125(5):e322-4. View Abstract

  54. Assessment of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the fine needle aspirates of metastatic breast carcinomas. Diagn Cytopathol. 2013 Apr; 41(4):308-15. View Abstract

  55. Nasal glioma: prenatal diagnosis and multidisciplinary surgical approach. Skull Base Rep. 2011 Nov; 1(2):83-8. View Abstract

  56. Papillary thyroid carcinoma in an autonomous hyperfunctioning thyroid nodule: case report and review of the literature. Thyroid. 2010 Sep; 20(9):1029-32. View Abstract

  57. Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2010 Jul 01; 54(7):1045-7. View Abstract

  58. Cytologic evaluation of image-guided fine needle aspiration biopsies via robotic microscopy: A validation study. J Pathol Inform. 2010 May 26; 1. View Abstract

  59. Diagnostic accuracy and limitations of fine-needle aspiration cytology of bone and soft tissue lesions: a review of 1114 cases with cytological-histological correlation. Cancer Cytopathol. 2010 Feb 25; 118(1):24-32. View Abstract

  60. Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. Cancer. 2009 Oct 25; 117(5):338-48. View Abstract

  61. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol. 2009 Nov 01; 27(31):5182-8. View Abstract

  62. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases. Hum Pathol. 2010 Jan; 41(1):94-102. View Abstract

  63. Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: results of a randomized controlled trial. J Nutr Health Aging. 2009 Aug; 13(7):623-30. View Abstract

  64. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. 2008 Dec 01; 113(11):3242-7. View Abstract

  65. Fine needle aspiration biopsy: role in diagnosis of pediatric head and neck masses. Int J Pediatr Otorhinolaryngol. 2008 Oct; 72(10):1547-53. View Abstract

  66. Head and neck epithelioid sarcoma in a child: diagnostic dilemma and anterolateral thigh free flap reconstruction. Int J Pediatr Otorhinolaryngol. 2008 May; 72(5):719-24. View Abstract

  67. Array comparative genomic hybridization analysis of solid pseudopapillary neoplasms of the pancreas. Mod Pathol. 2008 May; 21(5):559-64. View Abstract

  68. Utility of glypican-3, alpha-fetroprotein, and HepPar-1 as a panel for detecting hepatocellular carcinomas in fine needle aspiration biopsies. 2008.

  69. Cytological evaluation of image-guided fine needle aspiration biopsies via robotic microscopy: a pilot validation study. 2008.

  70. Fluorescence in-situ hybridization (FISH) studies on direct smears: an approach to enhance the fine needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. 2008.

  71. Assessment of estrogen receptor (ER), progesterone receptor (PR) and Her2/neu status in fine needle aspirates of metastatic breast carcinomas. 2008.

  72. Diagnostic values of endobronchial ultrasound-guided fine needle aspiration biopsy (EBUS-FNAB) in assessment of mediastinal lymphdenopathy. 2008.

  73. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007 Dec; 46(12):1051-60. View Abstract

  74. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Am J Surg Pathol. 2007 Jun; 31(6):895-901. View Abstract

  75. Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. J Clin Oncol. 2007 May 20; 25(15):2057-62. View Abstract

  76. The problems and promise of central pathology review: development of a standardized procedure for the Children's Oncology Group. Pediatr Dev Pathol. 2007 May-Jun; 10(3):199-207. View Abstract

  77. Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children's Oncology Group study. Pediatr Dev Pathol. 2007 Mar-Apr; 10(2):89-97. View Abstract

  78. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. Am J Surg Pathol. 2006 Aug; 30(8):962-8. View Abstract

  79. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest. 2006 Jun; 86(6):547-56. View Abstract

  80. Ewing's sarcoma family of tumors: current management. Oncologist. 2006 May; 11(5):503-19. View Abstract

  81. ASCP Check Sample: Cytopathology Number C-10 2006. FNA of masses arising at the angle of the jaw in pediatric patients. 2006.

  82. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. Principles and Practice of Pediatric Oncology. Pizzo PA, Polick DG. 2006; 1002-1032.

  83. Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States. J Urol. 2005 Oct; 174(4 Pt 1):1238-41. View Abstract

  84. Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation. Pediatr Transplant. 2005 Feb; 9(1):112-6. View Abstract

  85. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol. 2005 Jan-Feb; 8(1):141. View Abstract

  86. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Pediatr Dev Pathol. 2004 Nov-Dec; 7(6):583-94. View Abstract

  87. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 2004 May 15; 22(10):1902-8. View Abstract

  88. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; 9(4):422-41. View Abstract

  89. Tech Sample: Cytotechnology Number CY-5 2004. Small round cell sarcomas: Cytologic diagnosis of alveolar rhabdomyosarcoma and extraosseous Ewing sarcoma. 2004.

  90. Bone Tumors. Cancer Medicine-6. Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Jr, Gansler TS, Holland JF, Frei E III. 2003; 2383-2403.

  91. Parathyroid hormone-related Peptide expression in cartilaginous tumors. Clin Orthop Relat Res. 2002 Oct; (403):198-204. View Abstract

  92. Angiocentric T-cell lymphoma of the temporal bone. Otolaryngol Head Neck Surg. 2002 Jan; 126(1):85-6. View Abstract

  93. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. J Clin Oncol. 2001 Oct 15; 19(20):4058-64. View Abstract

  94. Free osteocutaneous scapular apophysis flap for reconstruction of the lateral malleolus. Ann Plast Surg. 2001 Sep; 47(3):328-31. View Abstract

  95. Routine brain imaging is unwarranted in asymptomatic patients with rhabdomyosarcoma arising outside of the head and neck region that is metastatic at diagnosis: a report from the Intergroup Rhabdomyosarcoma Study Group. Cancer. 2001 Jul 01; 92(1):121-5. View Abstract

  96. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. J Pediatr Hematol Oncol. 2001 May; 23(4):225-33. View Abstract

  97. Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study. J Clin Oncol. 2001 Jan 01; 19(1):213-9. View Abstract

  98. Cyclosporin A (CSA) to overcome multiple drug resistance in osteogenic sarcoma (OS): A Pediatric Oncology Group study (POG 9351). Med Pediatr Oncol. 2001; 37:177.

  99. Myogenin is the primary immunostain to identify rhabdomyosarcoma (RMS) versus other malignant or reactive lesions. Mod Pathol. 2000; 13:2P.

  100. Undifferentiated embryonal sarcoma of the liver (UESL) is not biliary tree rhabdomyosarcoma (BTRMS). Mod Pathol. 2000; 13:4P.

  101. Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia? Acta Neuropathol. 2000 Jan; 99(1):67-72. View Abstract

  102. Use of free scapular crest flap in pediatric epiphyseal reconstructive procedures. Clin Orthop Relat Res. 1999 Aug; (365):211-20. View Abstract

  103. Orthopedic short stories: Lytic lesion of the talus. American Academy of Orthopedic Surgeons (on-line). 1999.

  104. Tech Sample: Cytotechnology Number CY-5 1999. Giant cell lesions of bone: An integrated approach to diagnosis. 1999.

  105. Histopathologic practices for esophageal biopsy specimens: survey results and implications for surveillance in patients with Barrett's esophagus. Am J Clin Pathol. 1998 Aug; 110(2):219-23. View Abstract

  106. In vitro characterization of interactions of prostate cancer cell lins with bone: A potential model for bone metastasis. Lab Invest. 1998; 78:166A.

  107. Dedifferentiated chondrosarcoma: An immunohistochemical study. Lab Invest. 1998; 78:16A.

  108. Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction. Iowa Orthop J. 1998; 18:26-34. View Abstract

  109. Mechanisms of bone metastasis. Assessment and Treatment of Cancer Pain: Progress in Pain Research and Management. Payne R, Patt R, Hill CS. 1998; 12.

  110. Fine needle aspiration of the liver and pancreas. Atlas of Difficult Diagnoses in Cytopathology. Atkinson BF, Silverman JF. 1998; 327-349.

  111. P-glycoprotein expression in cartilaginous tumors. J Surg Oncol. 1997 Jun; 65(2):95-105. View Abstract

  112. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab Invest. 1997 Apr; 76(4):457-65. View Abstract

  113. Neoplasms and tumor-like lesions of bone. Principles and Practice of Surgical Pathology and Cytopathology. Silverberg SG, DeLellis RA, Frable WJ. 1997; 863-941.

  114. Review of: Fine Needle Aspiration Biopsy of the Head and Neck. Am J Clin Pathol. 1997; 107:617-618.

  115. Heterotopic ossification in sigmoid colon carcinoma: Expression of osteoinductive factors by tumor cells may explain stromal bone formation. Lab Invest. 1997; 76:154A.

  116. Fine-needle aspiration biopsy of synovial sarcoma. A cytomorphologic analysis of primary, recurrent, and metastatic tumors. Am J Clin Pathol. 1996 Dec; 106(6):769-75. View Abstract

  117. Mollaret's meningitis: case report with immunocytochemical and polymerase chain reaction amplification studies. Diagn Cytopathol. 1996 Nov; 15(4):345-8. View Abstract

  118. Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation. Hum Pathol. 1996 Jul; 27(7):625-32. View Abstract

  119. Fine-needle aspiration cytology of metastatic small cell carcinoma of the colon: a report of three cases. Diagn Cytopathol. 1996 Jul; 15(1):54-9. View Abstract

  120. Localization of cytokines and matrix metalloproteinase production in pigmented villonodular synovitis. Mod Pathol. 1996; 9:14A.

  121. Cytokine expression in Langerhans cell histiocytosis of bone: an immunohistochemical study. Mod Pathol. 1996; 9:5A.

  122. Cytokine expression in Ewing's sarcoma/primitive neuroectodermal tumor: A possible mechanism mediating osteoclastic activity and bone destruction. Trans Orthop. Res. Soc. 1996; 21:182A.

  123. Fine needle aspiration biopsy of synovial sarcoma: A cytomorphologic analysis of primary, recurrent, and metastic tumors. Acta Cytol. 1996; 40:1089.

  124. Mast cell disease presenting as a solitary skeletal lesion: a report of three cases. Mod Pathol. 1996; 9:13A.

  125. Myositis ossificans: Variations in fine needle aspiration biopsy cytology correlate with lesional maturation. Acta Cytol. 1996; 40:1089.

  126. Immunohistochemical detection of P-glycoprotein in rhabdomyosarcoma: correlation with patient outcome. Mod Pathol. 1996; 9:8A.

  127. Cytokine and growth factor expression in carcinomas with skeletal metastasis. J Bone Min Res. 1996; 11(supplement 1):S360A.

  128. Low-grade chondrosarcoma in a 12-year-old boy. Skeletal Radiol. 1995 Aug; 24(6):466-8. View Abstract

  129. Immunocytochemical localization of lysosomal enzymes in skeletal disorders with abnormal bone remodeling. Mod Pathol. 1995; 8:240A.

  130. Diagnostic esophageal cytology and its histopathologic basis. The Esophagus. Castell DO. 1995; 179-204.

  131. Segmental agenesis of small intestional muscularis propria. 1995.

  132. Expression of resorption stimulating cytokines by osteoclasts: Evidence for autocrine/paracrine regulation. J Bone Min Res. 1995; 10(supplement 1):M332A.

  133. Fine needle aspiration biopsy of bone lesions: clinical radiographic and histologic correleations. Mod Pathol. 1995; 8:240A.

  134. Multiple drug resistance in osteosarcoma. Iowa Orthop J. 1995; 15:66-73. View Abstract

  135. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis. Cancer. 1994 Dec 15; 74(12):3227-33. View Abstract

  136. Low amniotic fluid glucose levels are a specific but not a sensitive marker for subclinical intrauterine infections in patients in preterm labor with intact membranes. Am J Obstet Gynecol. 1994 Aug; 171(2):365-70; discussion 370-1. View Abstract

  137. The use of scapular skin island flaps in the treatment of axillary postburn scar contractures. Br J Plast Surg. 1994 Mar; 47(2):108-11. View Abstract

  138. Fine needle aspiration cytology of metastatic small cell carcinoma of the colon: A report of three cases with ancillary studies. Acta Cytol. 1994; 38:836.

  139. Further investigation of Mollaret's cells. Acta Cytol. 1994; 38:875.

  140. Histiocytoid cardiomyopathy: case report and literature review. J Forensic Sci. 1993 Nov; 38(6):1427-35. View Abstract

  141. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol. 1993 Oct; 169(4):1035-44. View Abstract

  142. Unbalanced mosaic karyotypes with different structural abnormalities involving a common chromosome region: report of two cases. Am J Med Genet. 1993 Feb 01; 45(3):365-9. View Abstract

  143. Diagnostic esophageal cytology: An overview. Cytopathology Annual. Schmidt WA, Miller TR. 1993; 89-114.

  144. Review of: Gastrointestinal Pathology and Its Clinical Implications Vol 2. JAMA. 1993; 269:2147-2148.

  145. Positive tests for cytomegalovirus in AIDS patients (letter). Am J Gastroenterol. 1993; 88:1800-1801.

  146. Pedicle scapular apophysis transplantation in congenital limb malformations. Ann Plast Surg. 1992 Oct; 29(4):332-40. View Abstract

  147. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer. 1992 Jan 01; 69(1):8-16. View Abstract

  148. Diagnostic esophageal cytology and its histopathologic basis. The Esophagus. Castell DO. 1992; 187-216.

  149. Exfoliative and aspiration cytomorphology of intraabdominal desmoplastic small round cell tumor: the first reported case. Acta Cytol. 1992; 599.

  150. A comparative cytopathologic and histologic study of aypia, dysplasia and adenocarcinoma in Barrett's esophagus. Cancer. 1992; 69(1):8-16.

  151. Barrett's esophagus: The complementarity of endoscopic cytologic brushings and biopsies and DMA ploidy by image analysis. Acta Cytol. 1992; 36:624.

  152. Review of: Gastrointestinal Pathology and Its Clinical Implications Vols 1. JAMA. 1992; 269:2147-2148.

  153. Cytologic diagnosis of cytomegaloviral esophagitis: A report of three acquired immunodeficiency syndrome-related cases. Acta Cytol. 1991; 35:599.

  154. Gastrointestinal cytology. Chin Lab Med. 1991; 11(2):403-441.

  155. Barrett's esophagus: A comparative cytolgic and histologic study of atypia, dysplasia and adenocarcinoma. Lab Invest. 1990; 62:99A.

  156. Laboratory identification of ischemic hepatitis (shock liver). 1988.

  157. Laboratory identification of ischemic hepatitis (shock liver). 1988.

  158. The free scapular flap. Plast Reconstr Surg. 1982 Apr; 69(4):601-4. View Abstract
BESbswy